BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 38303001)

  • 21. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
    Li JL; Hou W
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of
    Yao L; Zhang X; Huang C; Cai Y; Wan CC
    Biomed Res Int; 2023; 2023():6407588. PubMed ID: 36726839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer.
    Zhang S; Wang J; Zhang H
    Medicine (Baltimore); 2023 Nov; 102(44):e35826. PubMed ID: 37933017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics.
    Le-Xin C; Ming-Jun L; Chun-Qi X; Jia-Xin Z; Jing-Ya Y; Li-Xin N; Mei-Qi W; En-Xin Z; Xiao-Jun Z
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116943. PubMed ID: 37532072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncovering the anti-NSCLC effects and mechanisms of gypenosides by metabolomics and network pharmacology analysis.
    Qi YS; Xie JB; Xie P; Duan Y; Ling YQ; Gu YL; Piao XL
    J Ethnopharmacol; 2021 Dec; 281():114506. PubMed ID: 34371113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K/AKT1 signaling pathway in non-small cell lung cancer.
    Zhang L; Gong Y; Zhang L; Liang B; Xu H; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Li M; Huang Y; Wang Y; Yang L
    Front Oncol; 2022; 12():1034750. PubMed ID: 36591458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating Network Pharmacology and Bioinformatics to Explore the Effects of Dangshen (
    Yu Y; Ding S; Xu X; Yan D; Fan Y; Ruan B; Zhang X; Zheng L; Jie W; Zheng S
    Drug Des Devel Ther; 2023; 17():659-673. PubMed ID: 36883114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of phytochemical compounds of
    Zhang M; Zhang X; Pei J; Guo B; Zhang G; Li M; Huang L
    Heliyon; 2023 Mar; 9(3):e14029. PubMed ID: 36911881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking.
    Zhang FY; Guo SC
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9192-9204. PubMed ID: 37843333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
    J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
    Tu H; Li J; Xu W; Wang Z; Wang L
    Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
    Gu M; Su W; Dai J; Wang J; Jia X; Yao J; Zhang G; Zhu Q; Pang Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116899. PubMed ID: 37454750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanism of Qilongtian Capsules in treatment of acute lung injury based on network pharmacology prediction and experimental validation].
    Xie Y; Su XR; Zhou T; Liang YY; Wu YQ; Wan Y; Lu TL; Zhao XL; Li ZY
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4187-4200. PubMed ID: 37802787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms predictive of Tibetan Medicine Sophora moorcroftiana alkaloids for treatment of lung cancer based on the network pharmacology and molecular docking.
    Ji P; Zhao NS; Wu FL; Wei YM; Laba CD; Wujin CM; Hua YL; Yuan ZW; Yao WL
    BMC Complement Med Ther; 2024 Jan; 24(1):47. PubMed ID: 38245694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network Pharmacology Combined with GEO Analysis of the Mechanism of Qing-Jin-Hua-Tan Decoction in the Treatment of Non-small Cell Lung Cancer.
    Wei Y; Liu C
    Curr Comput Aided Drug Des; 2024; 20(4):396-404. PubMed ID: 37231755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the pharmacological and molecular mechanisms of Salvia chinensis Benth in colorectal cancer: A network pharmacology and molecular docking study.
    Zheng Q; Wang X; Gao T; Zhang B; Zhao N; Du R; Zhao Z
    Medicine (Baltimore); 2023 Dec; 102(50):e36602. PubMed ID: 38115259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular mechanism of Spatholobi Caulis in treatment of lung cancer based on network pharmacology and molecular docking].
    Chen K; Jin C; Cheng YY; Zhang QX; Li XX; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):837-844. PubMed ID: 33645088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effects of Siegesbeckia orientalis L. and its active compound luteolin in rheumatoid arthritis: network pharmacology, molecular docking and experimental validation.
    Xiao B; Li J; Qiao Z; Yang S; Kwan HY; Jiang T; Zhang M; Xia Q; Liu Z; Su T
    J Ethnopharmacol; 2023 Dec; 317():116852. PubMed ID: 37390879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.